It’s been a very rough week for health care reform. So happy holidays from your favorite Congressional representatives and lobbying groups!
If it happens at all (no certainty now), it will be more modest than many people had hoped for—no public option and no early Medicare buy-in for those between ages 55 and 65. The reason comes down to a handful of Senators, as we’ve mentioned before. But the ultimate reason is due to two problems that stymie important legislation in general (and threaten America’s ability to adapt to a rapidly changing global economy and environment). One is constitutional and one legislative:
a. The constitutional one: As one person writing in response to a health care blog pointed out: the Senate gives more votes to trees than to citizens in many states. California has almost 37 million people—as many as the bottom 19 states in population. But it gets only 2 Senate votes, while they (Wyoming, Alaska, Nebraska, Idaho, etc.) get 38 votes. Thus there is a huge disconnect between popular opinion and legislation, greatly favoring rural (and generally more conservative) states.
b. The legislative one: years ago the Senate enacted the 60-vote rule to overcome filibusters, at a time when these were relatively rare. Now filibusters are used by the minority party as much as possible (according to a Washington Post columnist, “in the 2007-08 session of Congress, Republicans forced 112 cloture votes, nearly doubling the Democrats’ record when they were in the minority.”). Neither party is eager to change the rule, since it gives them some protection whenever circumstances might shift them to minority status. The Senate could change the rules and reduce the number of votes needed to overcome a filibuster and reach “cloture.” They did this in 1975, reducing the threshold from 67 votes to the current 60.
In the middle of last week, Senate Majority Leader Harry Reid thought he had found a good compromise that would get him the necessary 60 votes. Here are some very sketchy details (no written specifics are yet available):
− Scrap the government-run public option, except for still having it get “triggered” under certain circumstances,
− Allow for an early Medicare buy-in for those between ages 55 and 65 and for individual coverage only (no family policies),
− Create a private nonprofit insurance plan (possibly run by Blue Cross), to be overseen by the Office of Personnel Management (the “OPM,” the federal agency that oversees the insurance program used by members of Congress)
− Allow buy-in to the Federal Employees Health Benefits Program (FEHBP).
But the more conservative Senate Democrats and the one Republican whose vote is being courted, Olympia Snowe, are firmly or leaning against the Medicare buy-in for the following claimed reasons:
− It would further aggravate the Medicare funding deficit by likely allowing people to buy-into it at less than full cost. If people were charged full cost (estimated at anywhere from $7,000 or more per person per year!), they could not afford it, especially those who would need it the most—those who were laid off or can’t afford coverage from insurance companies.
− It would create that “slippery slope” to a single payer, government-run program.
− It pays hospitals and doctors much less than what insurance companies pay them. While those who run Medicare and many other experts say that Medicare generally pays fairly, hospital and physician associations of course would argue otherwise and expectedly are fighting hard to stop this.
− Medicare benefits are not that great anyway and most people over 65 have to buy supplements to fill in the gaps.
Those in favor of the early Medicare buy-in claim it has the following advantages:
− It would be more affordable than private insurance coverage, which many might not otherwise even be able to get, due to pre-existing conditions limits or other restrictions.
− It would save the government more money, since when the coverage is subsidized (though not planned for in the bill until 2014), it would save the government money since Medicare costs less than comparable private coverage and thus the subsidies could be lower.
− It gives Medicare more enrollees and thus more clout to encourage providers to adopt delivery system reforms.
The individual who originally proposed the public option idea, Professor Jacob Hacker of Yale, was also very skeptical of the alternatives proposed by Senator Reid this past week. The so-called national private plan that would be run by the OPM likely would be just another Blue Cross Blue Shield plan, which already has a virtual monopoly in most areas of the country— how would this save any thing if it is only “competing” against its own other plans? In a column in the online version of the New Republic (http://www.tnr.com/blog/the-treatment/public-plan-perversion), Hacker elaborates on his criticisms and reiterates the value of the public option:
“(1) it will significantly reduce costs; (2) it will provide broad, transparent coverage at an affordable price, setting a benchmark private insurers will be pressed to follow; (3) it won’t be in the business of denying or delaying needed care to people with costly conditions or shifting excessive costs onto them; and (4) it’s a vehicle for driving delivery and payment system reforms that private plans have proven unable and/or unwilling to do. Since we live in a democracy, it also seems relevant that (5) the public plan has been consistently popular with Americans (and doctors, according to a recent survey in the New England Journal of Medicine [3]), despite the unrelenting false attacks on it.”
Senator Reid got somewhat bad news on Friday from a report by the Center for Medicare and Medicaid Services, which concluded the initial Senate bill would slightly raise total public and private spending over the next 10 years by 0.7 percent (vs. doing nothing), rather than reduce it. Of course, opponents have seized on this “headline” without mentioning the more positive specifics:
− The bill would provide good coverage to most of the 47 million uninsured
− It would require better coverage to the additional 40-50 million who are “underinsured” (have lousy policies with a lot of dollar limits, high deductible that they cannot afford, or exclude many health conditions)
− The bill would help control costs after the initial 10 years during which the coverage expansions, subsidies, and cost management mechanisms are set up. The report says the initial Senate bill would extend the life of the Medicare trust fund by 9 more years.
A key problem, as we’ve noted before, is that both this governmental actuarial group and the Congressional Budget Office (CBO), which is charged with the official scoring of the bills, are very conservative in recognizing any savings for any new health delivery system reforms. But besides covering the uninsured and providing subsidies for many others to make coverage more affordable, these delivery system changes are central reason for health care reform—to bend the costs curve and get the US more in line with the rest of the advanced world economies who spend half to 2/3rds of what we spend, while covering everyone. We have no choice but to adopt these reforms before the country and more individuals go bankrupt.
In a blog on the Politico web site, health care law expert, Professor Timothy Jost, gets to the heart of the issue for the CBO and others claiming to cost projections of the legislation:
“Foster [the lead actuary drafting the report by the Center for Medicare and Medicaid Services] is skeptical of the productivity adjustments imposed on Medicare provider payments by the Senate bill, stating, “While such payment update reductions would provide a strong incentives for providers to maximize efficiency, it is doubtful that many could improve their own productivity to the degree achieved by the economy at large.” A footnote points out that productivity gains in hospitals have been “small or negligible during 1981 to 2003.” If it is impossible for health care providers to improve their efficiency and productivity, then not only is health care reform at risk, our entire economy is at risk. We simply cannot continue to expand payments for health care at historic rates if our country is to survive. The fatalistic conclusion of Mr. Foster is not acceptable.” (Politico, Dec. 13, http://www.politico.com/arena/)
See the following stories for more on the urgency of cost controls:
− “Testing, Testing,” by Atul Gawande in the Dec. 14th New Yorker (http://www.newyorker.com/reporting/2009/12/14/091214fa_fact_gawande?currentPage=all), which discusses why there need to be so many pilot, or experimental, programs in the legislation for delivery system reform (these provisions represent almost half of the Senate bill’s 2074 pages).
− “Finding the Nerve to Cut Health Costs,” in the Dec. 9 New York Times column “Economic Scene,” By David Leonhardt, which summarizes steps being taken by Senators and others to further expand cost controls in the legislation (http://www.nytimes.com/2009/12/09/health/policy/09leonhardt.html?_r=1&hp)
− “Business Roundtable edges away from health reform plan,” at the Politico web site on December 11 (http://www.politico.com/news/stories/1209/30502.html), which notes that the Business Roundtable group of 161 jumbo US employers is balking at the currently proposed legislation unless it does even more to control costs. The article describes several of the changes they want and are in discussion with Congress to resolve. They are also critical of some of the proposed fees that would add to their insurance costs and of the very weak individual mandate that would still allow people to waive coverage until they needed care, thus causing and driving up premium costs for everyone else. Their concerns are being taken very seriously, since they have been supporters of the reform effort so far but could turn against it if not pleased with its present direction.
The bill now being modified with these latest changes is due to get its official “score” from the Congressional Budget Office (CBO) perhaps today.
So, where are we? It partly comes down to what the House will accept from the Senate. Here are the possible scenarios:
a. If the House will also accept it (in the final joint House-Senate conference bill vote), the Senate could get 60 votes for a bill without the public option and early Medicare buy-in. House majority leader Nancy Pelosi has hinted that this might be possible and might allow bypassing the usual joint House-Senate conference resolution of the two passed bills. If a joint conference bill goes to vote, some liberal Representatives and Senators have said they will not vote for it if it does not include the public option of at least the Medicare buy-in.
b. If the House will not also accept such a Senate bill, then either:
i. The Senate needs to go back to the “reconciliation” approach talked about much earlier this year, which is a way to get around the 60-vote threshold needed to overcome a filibuster. Reconciliation can be used for financially significant bills and needs only a simple majority vote to pass. The Senate legislation then might need to be split into two bills—a predominantly financial one on Medicare reforms and subsidies and a predominantly nonfinancial one on regulatory reforms (insurance company reforms, the exchanges, etc.).
ii. Or: the Senate passes its bill without the public option and early Medicare buy-in and then one or both of these are put back in during the joint conference committee session that combines the House and Senate bill. Then the final vote would need a straight 60 votes from the Senate to pass (but not subject to any more debate on details or amendments).
In any event, time is running out. We have this week and part of next week, and then a holiday break, during which everyone goes home and gets an earful from Tea Party “patriots” and lobbyists, who speak up more than supporters of the bill generally do, fueled by fairly unbalanced cable news and well-funded TV ads running against reform running more often than pro-reform ads. According to the online news site, the Huffington Post (12-11-09), “a host of conservative groups are ramping up their efforts to derail health care reform in Congress, spending more than $3.91 million for a fresh wave of ad buys in key states, according to data provided by a Democratic ad tracker. The U.S. Chamber of Commerce is leading the charge. The pro-business group is devoting an estimated $2.78 million dollars on ads over the next week. Health care reform opponents are already outpacing proponents when it comes to television purchases—these buys seems likely to expand the margin.”